R&D Chronic kidney disease: Challenges and upcoming technologies Highlighting the impact of kidney disease, and promoting awareness and research, is crucial.
Patients Challenges and opportunities with plasma-derived therapies This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
R&D Open science: disrupting scientific community collaboration The quiet rise of collaboration among pharma companies has never been more important.
R&D Making a difference for traumatic brain injury patients TBI is the leading cause of death and disability in young adults in the developed world.
R&D Allogeneic therapies: The future of cancer treatment? Allogeneic therapies could provide an answer to some of the drawbacks of autologous therapies.
R&D 12 Questions with Ben Wiegand 12 Question with Ben Wiegand: transforming healthcare from disease care to health care.
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
